Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05586386 · ClinicalTrials.gov registry record · Phase 1
Cherries Role in Gut Microbiota-liver-brain Function
A Phase 1 study, sponsored by Texas A&M University.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT05586386 is a Phase 1 study that has completed, run by Texas A&M University. The registered enrollment target is 60 participants.
The verdict
NCT05586386, a Phase 1 study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
Sweet cherries (Prunus avium) are a good source of bioactive compounds including dietary fiber and phytochemicals which have been credited with multiple health benefits, including anti-inflammatory and antioxidant properties as well as preventing obesity-related metabolic disorders. However, most studies have shown such benefits using in vitro or animal models. The aim of this study was to examine the influence of DSC consumption on obesity-associated inflammation, metabolic disorders, cognitive impairment, and gut dysbiosis in obese individuals.
Interventions
- OTHER Cherry group
- OTHER Placebo group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2021-09-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05586386
The ClinicalTrials.gov registry entry for NCT05586386 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cherry group is the first listed.
NCT05586386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05586386 about?
NCT05586386 is a clinical study titled "Cherries Role in Gut Microbiota-liver-brain Function". Sweet cherries (Prunus avium) are a good source of bioactive compounds including dietary fiber and phytochemicals which have been credited with multiple health benefits, including anti-inflammatory and antioxidant properties as well as preventing obesity-related metabolic disorders. However, most st...
What is the current status of trial NCT05586386?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2020-02-06. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT05586386?
The interventions under investigation include: Cherry group (OTHER), Placebo group (OTHER).
Who is sponsoring clinical trial NCT05586386?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.